Citation Impact
Citing Papers
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
2003 Standout
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
2000
Infective Endocarditis
2005 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Autism and tuberous sclerosis
1992
Infantile spasms in tuberous sclerosis complex
2001
The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC)
2007
Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study
1997
Comprehensive Mutation Analysis of TSC1 and TSC2—and Phenotypic Correlations in 150 Families with Tuberous Sclerosis
1999
Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds
2012
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
2008
Comparative Analysis and Genomic Structure of the Tuberous Sclerosis 2 (TSC2) Gene in Human and Pufferfish
1996
The Tuberous Sclerosis Complex
2006 Standout
Molecular Genetic and Phenotypic Analysis Reveals Differences between TSC1 and TSC2 Associated Familial and Sporadic Tuberous Sclerosis
1997
Pathogenesis and clinical features of psoriasis
2007 Standout
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
2000
Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without Progesterone
2004
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
2002
Juvenile idiopathic arthritis
2007 Standout
National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex
2000
Renal cell carcinoma in association with tuberous sclerosis in children
1996
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
2003 Standout
Apparent preferential loss of heterozygosity atTSC2 overTSC1 chromosomal region in tuberous sclerosis hamartomas
1996
Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors
2006
Tuberous sclerosis complex: Advances in diagnosis, genetics, and management
2007
The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex
2004
Renal angiomyolipomata
2004
Biological markers of intellectual disability in tuberous sclerosis
2007
gigas, a Drosophila Homolog of Tuberous Sclerosis Gene Product-2, Regulates the Cell Cycle
1999
Inherited Cancer Syndromes in Children and Young Adults
2010
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Mosaicism in Tuberous Sclerosis as a Potential Cause of the Failure of Molecular Diagnosis
1999
Nonresolving Inflammation
2010 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Molecular and clinical analyses of 84 patients with tuberous sclerosis complex
2006
Renal Cystic Disease in Tuberous Sclerosis: Role of the Polycystic Kidney Disease 1 Gene
1997
Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance
1998
Ophthalmic manifestations of tuberous sclerosis: a population based study
2001
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome
1994
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
1994
Upstream and downstream of mTOR
2004 Standout
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
2003 Standout
Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs
2001
PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
2004
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
2003 StandoutNobel
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
A Detection Scheme for Paraquat Poisoning: Validation and a Five-Year Experience in Australia
2001
Autism: Towards an Integration of Clinical, Genetic, Neuropsychological, and Neurobiological Perspectives
1996 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Phosphorylation and Functional Inactivation of TSC2 by Erk
2005 Standout
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Autophagy in the Pathogenesis of Disease
2008 Standout
Molecular genetic advances in tuberous sclerosis
2000
Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members
1998
Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex
2003
Tuberous sclerosis
2008 Standout
Malignant Gliomas in Adults
2008 Standout
Pathogenesis of Tuberous Sclerosis Subependymal Giant Cell Astrocytomas: Biallelic Inactivation ofTSC1orTSC2Leads to mTOR Activation
2004
Superiority of Denaturing High Performance Liquid Chromatography over single‐stranded conformation and conformation‐sensitive gel electrophoresis for mutation detection in TSC2
1999
The Neurology of mTOR
2014
Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis
2001
Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations
2007
Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis
1998
Acute Pancreatitis
1994 Standout
Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17
2003 Standout
Embolization of Renal Angiomyolipomata in Patients With Tuberous Sclerosis Complex
2005
TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1/TSC2 frequency ratios
2002
An epidemiological study of renal pathology in tuberous sclerosis complex
2004
Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis
1999
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
2001
AKT/PKB Signaling: Navigating the Network
2017 Standout
Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway
2002
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Sex differences in immune responses
2016 Standout
Neuropathology of tuberous sclerosis
2001
A common LRRK2 mutation in idiopathic Parkinson's disease
2005 Standout
The PI3K Pathway in Human Disease
2017 Standout
The GAP-Related Domain of Tuberin, the Product of the TSC2 Gene, is a Target for Missense Mutations in Tuberous Sclerosis
1997
Analysis of bothTSC1 andTSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis
1999
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways
2005
Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1
1995
Sexual Dimorphism in Innate Immunity
2017
Sex hormones and the immune response in humans
2005
A Calmodulin Binding Site in the Tuberous Sclerosis 2 Gene Product Is Essential for Regulation of Transcription Events and Is Altered by Mutations Linked to Tuberous Sclerosis and Lymphangioleiomyomatosis
2002
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
2004
Staphylococcus aureusInfections
1998 Standout
Neutrophil apoptosis and the resolution of infection
2008
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Hamartin and Tuberin Interaction With the G2/M Cyclin-Dependent Kinase CDK1 and Its Regulatory Cyclins A and B
2001
Human pancreatic tissue concentration of bactericidal antibiotics
1992
Genetic Causes of Brain Tumors: Neurofibromatosis, Tuberous Sclerosis, von Hippel-Lindau, and Other Syndromes
2007
Germ-Line Mutational Analysis of the TSC2 Gene in 90 Tuberous-Sclerosis Patients
1998
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
Influencing Behavior of Physicians Ordering Laboratory Tests
1993
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
2004 StandoutNobel
Brain Abnormalities in Tuberous Sclerosis Complex
2004
Subependymal giant cell tumors in tuberous sclerosis complex
2004
Antibody-Mediated Encephalitis
2018 Standout
Early Diagnosis of Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis
1998
RENAL LESION GROWTH IN CHILDREN WITH TUBEROUS SCLEROSIS COMPLEX
1998
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Small GTP-Binding Proteins
2001 Standout
Cortical Tuber Count: A Biomarker Indicating Neurologic Severity of Tuberous Sclerosis Complex
1997
Inability to Predict Diagnosis in Febrile Intravenous Drug Abusers
1987
Managing Epilepsy in Tuberous Sclerosis Complex
2004
Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
1996 StandoutNobel
Characterization of individual polynucleotide molecules using a membrane channel
1996 Standout
Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
2016
Evolution of Cardiac Rhabdomyoma in Tuberous Sclerosis Complex
1996
Influence of core temperature on autoresuscitation during repeated exposure to hypoxia in normal rat pups
1999
Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore
1996 StandoutScience
Life with 6000 Genes
1996 StandoutScience
Neuroimaging in tuberous sclerosis complex
2007
Conserved linkage between the puffer fish (Fugu rubripes) and human genes for platelet-derived growth factor receptor and macrophage colony-stimulating factor receptor.
1996 StandoutNobel
Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex
2005
Tuberous Sclerosis Consensus Conference: Recommendations for Diagnostic Evaluation
1999
The Tuberous Sclerosis Complex and its Highly Variable Manifestations
2003
Developmental enamel defects in tuberous sclerosis: a clinical genetic marker?
1997
Alpha-toxin of Staphylococcus aureus
1991
Functional Hydrogels as Wound Dressing to Enhance Wound Healing
2021 Standout
17β-Estradiol Protects Females against Influenza by Recruiting Neutrophils and Increasing Virus-Specific CD8 T Cell Responses in the Lungs
2014
Cognitive deficits in normally intelligent patients with tuberous sclerosis
1999
Herpes simplex virus‐induced anti‐N‐methyl‐d ‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases
2017
Dynamic Molecular Combing: Stretching the Whole Human Genome for High-Resolution Studies
1997 Science
Pathophysiology of Sleep Apnea
2010 Standout
Clinical and Genotype Studies of Cardiac Tumors in 154 Patients With Tuberous Sclerosis Complex
2006
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Behavioral and Cognitive Aspects of Tuberous Sclerosis Complex
2004
Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation
1999
LONG-TERM OUTCOME OF TRANSCATHETER EMBOLIZATION OF RENAL ANGIOMYOLIPOMAS DUE TO TUBEROUS SCLEROSIS COMPLEX
2005
Lymphangioleiomyomatosis
2006
The genetic basis of tuberous sclerosis
1998
Usefulness of Diagnostic Criteria of Tuberous Sclerosis Complex in Pediatric Patients
2000
Topical Review: Vigabatrin in the Treatment of Infantile Spasms in Tuberous Sclerosis: Literature Review
1999
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex
2016
Diagnosis of Tuberous Sclerosis Complex
2004
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
1996
Works of David Webb being referenced
Heat Illness in Infants and Young Children
1962
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Have Differential Effects on Neonatal and Adult Neutrophil Survival and Function
2005
MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY
1996
Thrombotic thrombocytopenic purpura: A treatable cause of childhood encephalopathy
1997
Tuberous sclerosis and polycystic kidney disease.
1993
Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13
1994
Anti-N-Methyl-D-Aspartate Receptor Antibody Mediated Neurologic Relapse Post Herpes Simplex Encephalitis
2016
Effects of Heat Shock and Hypoxia on Neonatal Neutrophil Lipopolysaccharide Responses: Altered Apoptosis, Toll-Like Receptor-4 and CD11b Expression Compared with Adults
2006
Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay
2009
Epidemiology of Tuberous Sclerosis
1991
Movement disorders in association with herpes simplex virus encephalitis in children: a review
1998
Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone
2003
Animal model for anaerobic lung abscess
1981
Skin and soft tissue polymicrobial infections from intravenous abuse of drugs.
1979
Cranial magnetic resonance imaging in patients with tuberous sclerosis and normal intellect.
1991
In Vitro Activity of Mezlocillin and Its Related Compounds Against Aerobic and Anaerobic Bacteria
1979
On the incidence of fits and mental retardation in tuberous sclerosis.
1991
Measurement of Paraquat in Serum by High-Performance Liquid Chromatography
1979
Rapid-onset dystonia-parkinsonism
2000 Nobel
Non-penetrance in tuberous sclerosis.
1991
Biochemical Testing in Patients With Alcoholic Liver Disease
1989
The cutaneous features of tuberous sclerosis: a population study
1996
Cardiac rhabdomyomas and their association with tuberous sclerosis.
1993
A population study of renal disease in patients with tuberous sclerosis
1994
Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies
2001
The cutaneous features of tuberous sclerosis: a population study
1996